These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4415589)

  • 1. Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
    Bordier P; Pechet MM; Hesse R; Marie P; Rasmussen H
    N Engl J Med; 1974 Oct; 291(17):866-71. PubMed ID: 4415589
    [No Abstract]   [Full Text] [Related]  

  • 2. Normophosphatemic vitamin D-resistant osteomalacia in a patient with normal calcium and fat absorption.
    Waron M; Stauffer M; Baylink D; Rich C
    Ann Intern Med; 1971 Sep; 75(3):415-9. PubMed ID: 5568153
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
    Peacock M; Aaron JE; Heyburn PJ; Nordin BE
    Adv Exp Med Biol; 1977; 81():431-40. PubMed ID: 899935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man.
    Peacock M; Gallagher JC; Nordin BE
    Lancet; 1974 Mar; 1(7854):385-89. PubMed ID: 4131034
    [No Abstract]   [Full Text] [Related]  

  • 6. Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D.
    Smith R; Dick M
    Clin Sci; 1968 Feb; 34(1):43-56. PubMed ID: 5640685
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of uremic osteoid to vitamin D.
    Memmos DE; Eastwood JB; Harris E; O'Grady A; de Wardener HE
    Kidney Int Suppl; 1982 May; 11():S50-4. PubMed ID: 6956774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
    Drezner MK; Feinglos MN
    J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
    Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL
    Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 25-hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy.
    Compston JE; Horton LW
    Gastroenterology; 1978 May; 74(5 Pt 1):900-2. PubMed ID: 640344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
    Lyles KW; Harrelson JM; Drezner MK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
    [No Abstract]   [Full Text] [Related]  

  • 12. Diseases contributing to fragility of bone in patients with hip fractures.
    Alhava EM
    Ann Clin Res; 1974 Aug; 6(4):246-52. PubMed ID: 4429337
    [No Abstract]   [Full Text] [Related]  

  • 13. Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.
    Long RG; Varghese Z; Meinhard EA; Skinner RK; Wills MR; Sherlock S
    Br Med J; 1978 Jan; 1(6105):75-7. PubMed ID: 620204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetracycline-based studies of bone dynamics in rib of 6 cases of osteomalacia.
    Ramser JR; Frost HM; Frame B; Arnstein AR; Smith R
    Clin Orthop Relat Res; 1966; 46():219-36. PubMed ID: 5915110
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure.
    Eastwood JB; Stamp TC; De Wardener HE; Bordier PJ; Arnaud CD
    Clin Sci Mol Med; 1977 May; 52(5):499-508. PubMed ID: 862343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypophosphatemic vitamin D-resistant osteomalacia treated with 1 alpha- hydroxyvitamin D3 (Etalpha)].
    Lauridsen UB; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 1980 Apr; 142(18):1154-5. PubMed ID: 7404688
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of serum, bone and urinary hydroxyproline in nutritional osteomalacia.
    Rizvi SN; Vaishnava H
    J Assoc Physicians India; 1973 Feb; 21(2):189-93. PubMed ID: 4792789
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
    Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H; Bordier P
    Contrib Nephrol; 1980; 18():184-91. PubMed ID: 7353375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.